Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Thomas G. McCloud is active.

Publication


Featured researches published by Thomas G. McCloud.


International Journal of Cancer | 2007

Reactivation of Kaposi’s sarcoma-associated herpesvirus by natural products from Kaposi’s sarcoma endemic regions

Denise Whitby; Vickie Marshall; Rachel Bagni; Wendell Miley; Thomas G. McCloud; Rebecca Hines-Boykin; James J. Goedert; Betty Conde; Kunio Nagashima; Judy A. Mikovits; Dirk P. Dittmer; David J. Newman

Kaposis sarcoma (KS) and its causative agent, Kaposis sarcoma associated herpesvirus (KSHV/HHV‐8), a gamma2 herpesvirus, have distinctive geographical distributions that are largely unexplained. We propose the “oncoweed” hypothesis to explain these differences, namely that environmental cofactors present in KS endemic regions cause frequent reactivation of KSHV in infected subjects, leading to increased viral shedding and transmission leading to increased prevalence of KSHV infection as well as high viral load levels and antibody titers. Reactivation also plays a role in the pathogenesis of KSHV‐associated malignancies. To test this hypothesis, we employed an in vitro KSHV reactivation assay that measured increases in KSHV viral load in KSHV infected primary effusion lymphoma (PEL) cells and screened aqueous natural product extracts from KS endemic regions. Of 4,842 extracts from 38 countries, 184 (5%) caused KSHV reactivation. Extracts that caused reactivation came from a wide variety of plant families, and extracts from Africa, where KSHV is highly prevalent, caused the greatest level of reactivation. Time course experiments were performed using 28 extracts that caused the highest levels of reactivation. The specificity of the effects on viral replication was examined using transcriptional profiling of all viral mRNAs. The array data indicated that the natural extracts caused an ordered cascade of lytic replication similar to that seen after induction with synthetic activators. These in vitro data provide support for the “oncoweed” hypothesis by demonstrating basic biological plausibility.


Journal of Natural Products | 2009

Inhibitors of the NF-κB activation pathway from Cryptocarya rugulosa.

Tamara L. Meragelman; Dominic A. Scudiero; R. Eric Davis; Louis M. Staudt; Thomas G. McCloud; John H. Cardellina; Robert H. Shoemaker

The nuclear factor-kappaB (NF-kappaB) signaling pathway is constitutively active in many types of cancers and is a potential therapeutic target. Using a cell-based assay for stability of inhibitor of kappa B (IkappaB), a critical regulator of NF-kappaB activity, we found that an organic solvent extract of the plant Cryptocarya rugulosa inhibited constitutive NF-kappaB activity in human lymphoma cell lines. The active components were identified as rugulactone, a new alpha-pyrone (1), and the known cryptocaryone (2). Rugulactone was the more active compound, exhibiting up to 5-fold induction of IkappaB at 25 microg/mL; maximal activity was observed with 10 h exposure of test cells to 1 or 2.


Journal of Natural Products | 2010

Isolation and characterization of minor analogues of silvestrol and other constituents from a large-scale re-collection of Aglaia foveolata.

Li Pan; Leonardus B S Kardono; Soedarsono Riswan; Heebyung Chai; Caroline M. Pannell; Djaja Doel Soejarto; Thomas G. McCloud; David J. Newman; A. Douglas Kinghorn

Two new minor silvestrol analogues [2-episilvestrol (1) and 2,5-diepisilvestrol (2)], together with a new 21-norbaccharane-type triterpene (3), two new 3,4-secodammarane triterpenes (4 and 5), and a new eudesmane sesquiterpene (6), as well as nine known compounds, were isolated from a large-scale re-collection of the CHCl(3)-soluble extract of the stem bark of Aglaia foveolata obtained in Kalimantan, Indonesia. The structures of the new compounds were established by interpretation of their spectroscopic data. All of the isolates were tested for cytotoxicity against HT-29 cells. The new silvestrol analogues, 1 and 2, were considerably less active as cytotoxic agents than silvestrol (7) and episilvestrol (5-episilvestrol) (8) against this cell line, showing the importance of the configuration at C-2 in mediating such activity within this compound class. Several of the compounds isolated were also evaluated in a NF-κB (p65) inhibition assay.


Journal of Natural Products | 2011

Histone Deacetylase Inhibitors from Burkholderia thailandensis

Paul Klausmeyer; Suzanne M. Shipley; Karina M. Zuck; Thomas G. McCloud

Bioactivity-guided fractionation of an extract of Burkholderia thailandensis led to the isolation and identification of a new cytotoxic depsipeptide and its dimer. Both compounds potently inhibited the function of histone deacetylases 1 and 4. The monomer, spiruchostatin C (2), was tested side by side with the clinical depsipeptide FK228 (1, Istodax, romidepsin) in a murine hollow fiber assay consisting of 12 implanted tumor cell lines. Spiruchostatin C (2) showed good activity toward LOX IMVI melanoma cells and NCI-H522 non small cell lung cancer cells. Overall, however, FK228 (1) showed a superior in vivo antitumor profile in comparison to the new compound.


Journal of Biomolecular Screening | 2009

Overcoming Problems of Compound Storage in DMSO: Solvent and Process Alternatives

Timothy J. Waybright; John R. Britt; Thomas G. McCloud

The common practice of preparing storage libraries of compounds in 100% DMSO solution well in advance of bioassay brings with it difficulties that affect the accuracy of the data obtained. This publication presents a series of studies done on a subset of compounds that are difficult to bioassay because they precipitate from DMSO solution. These compounds are members of a frequently used, diverse compound library of the sort commonly used in the high-throughput screening (HTS) environment. Experiments were performed to determine the concentration of drug in solution above the precipitate, observe the time course and effect of various mixtures of solvents upon precipitation, measure the viscosity of cosolvents to determine compatibility with HTS, determine water absorption rates for various solvent combinations, and investigate resolubilization techniques to ensure proper drug solution for HTS. Recommendations are made on how to best maximize the probability that problem compounds will remain in solution, be accurately transferred during assay plate production, and, as a result, be accurately bioassayed at the specified molar concentration. (Journal of Biomolecular Screening 2009:708-715)


Journal of Chromatography A | 1991

Laser-light-scattering detection for high-speed countercurrent chromatography

Daniel E. Schaufelberger; Thomas G. McCloud; John A. Beutler

High-speed counter-current chromatography (HSCCC) is a powerful separation technique increasingly used in natural products chemistry. Evaporative laser light-scattering detection (ELSD) represents a universal detection method based on the following principle: the eluate [e.g. from a high-performance liquid chromatographic (HPLC) column] is nebulized and vaporized, leaving fine particles of solute in a carrier gas stream. These particles pass through a laser beam, scatter the light, and the scattered light is detected. The response is a function of the mass of solute passing through the detector


Journal of Natural Products | 2010

Schweinfurthins I and J from Macaranga schweinfurthii.

Paul Klausmeyer; Que N. Van; Johnson Jato; Thomas G. McCloud; John A. Beutler

Demand for the experimental antineoplastic agent schweinfurthin A, for developmental testing, prompted a re-collection of leaf material of Macaranga schweinfurthii from the original collection site in Cameroon. During chromatographic purification of the organic solvent extract, analytical UPLC-PDA-TOFMS of stilbene-enriched fractions revealed the presence of six known schweinfurthins and two previously unknown stilbenes. The structures of these new compounds, schweinfurthins I and J (1 and 2), were elucidated by 1D- and 2D-NMR techniques.


Journal of Natural Products | 2009

Cytotoxic and HIF-1α inhibitory compounds from Crossosoma bigelovii.

Paul Klausmeyer; Qin Zhou; Dominic A. Scudiero; Badarch Uranchimeg; Giovanni Melillo; John H. Cardellina; Robert H. Shoemaker; Thomas G. McCloud

Cytotoxicity-guided fractionation of an organic solvent extract of the plant Crossosoma bigelovii led to the discovery of a new strophanthidin glycoside (1) and two new 2-methylchromone glycosides (2 and 3). Also isolated were the known chromones eugenin and noreugenin, the indole alkaloid ajmalicine, the dibenzylbutane lignan secoisolariciresinol, the dibenzylbutyrolactone lignan matairesinol, and the furanone 5-tetradec-5-enyldihydrofuran-2-one. Further investigation into the biological properties of strophanthidin glycosides revealed a connection between inhibition of HIF-1 activation and the glycosylation of the genin. This work is the first published study of the bioactive phytochemicals of the family Crossosomataceae.


Journal of Natural Products | 2009

An Inhibitor of CCL2-Induced Chemotaxis from the Fungus Leptoxyphium sp.

Paul Klausmeyer; O. M. Zack Howard; Suzanne M. Shipley; Thomas G. McCloud

A biological screen used to identify inhibitors of monocyte chemotactic protein-1 (CCL2)-induced chemotaxis was applied in the activity-guided fractionation of an extract from a fungus of the genus Leptoxyphium sp. Inhibition of CCL2-induced chemotaxis was traced to a new dichlorinated diketopiperazine, cyclo(13,15-dichloro-L-Pro-L-Tyr). A structure-activity relationship (SAR) study evaluating relative activities of cyclo(13,15-dichloro-L-Pro-L-Tyr) and a nonchlorinated homologue cyclo(L-Pro-L-Tyr) showed that the dichlorinated molecule was 10- to 20-fold more active than the nonchlorinated form, while no activity was observed for cyclo(D-N-methylLeu-L-Trp).


Planta Medica | 2008

Separation and SAR Study of HIF-1α Inhibitory Tubulosines from Alangium cf. longiflorum

Paul Klausmeyer; Thomas G. McCloud; Badarch Uranchimeg; Giovanni Melillo; Dominic A. Scudiero; John H. Cardellina; Robert H. Shoemaker

A crude organic solvent extract of Alangium cf. longiflorum exhibited potent inhibition of hypoxia-induced HIF-1 transcriptional activity in human U251 glioma cells. Dereplication and bioactivity-guided fractionation, including Sephadex LH-20 and chiral HPLC chromatographies, led to the isolation of tubulosine ( 1), 9-desmethyltubulosine ( 2), and isotubulosine ( 3). Structures were verified by complete (1)H and (13)C assignments using 1D- and 2D-NMR techniques. Tubulosine strongly inhibited HIF-1 transcriptional activity, isotubulosine was devoid of activity, and 9-desmethyltubulosine possessed 6-fold less potency than tubulosine.

Collaboration


Dive into the Thomas G. McCloud's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Paul Klausmeyer

Science Applications International Corporation

View shared research outputs
Top Co-Authors

Avatar

Robert H. Shoemaker

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

John A. Beutler

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Dominic A. Scudiero

Science Applications International Corporation

View shared research outputs
Top Co-Authors

Avatar

David J. Newman

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Gordon M. Cragg

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

Gary M. Muschik

Science Applications International Corporation

View shared research outputs
Top Co-Authors

Avatar

Giovanni Melillo

Science Applications International Corporation

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge